Braizon Therapeutics

Hongo, Japan

Braizon Therapeutics is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University.

Jul 2021

Series B

Biotechnology Education Health Care Medical

Top Investors

SMBC Venture CapitalFast Track InitiativeInc.UTokyo Innovation Platform

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Braizon Therapeutics

Who are Braizon Therapeutics's investors?

Braizon Therapeutics's investors include SMBC Venture Capital, Fast Track Initiative, Inc., UTokyo Innovation Platform.

Where is Braizon Therapeutics headquartered?

Braizon Therapeutics is headquartered in Hongo, Japan.

What does Braizon Therapeutics do?

Braizon Therapeutics is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University.

What stage is Braizon Therapeutics at?

Braizon Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 9, 2021.

MLA

"Braizon Therapeutics — Funding & Investors." VCBacked, July 9, 2021, https://www.vcbacked.co/company/braizon-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Braizon Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/braizon-therapeutics

Wikipedia (cite web)

{{cite web |title=Braizon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/braizon-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 9, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.